Arrowhead Pharmaceuticals, Inc. (LON:0HI3)

Arrowhead Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is October - September.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 8, 2025	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Market Capitalization	6,263	3,547	1,797	2,360	3,139	4,821
Market Cap Growth	243.28%	97.45%	-23.88%	-24.82%	-34.88%	41.53%
Enterprise Value	6,153	3,408	1,818	2,294	2,857	4,456
Last Close Price	45.77	25.22	14.30	22.39	29.48	46.19
PS Ratio	10.15	5.75	678.12	11.96	14.38	47.07
PB Ratio	16.72	9.47	12.60	10.03	8.36	15.92
P/TBV Ratio	18.33	10.39	13.61	11.03	9.05	16.47
P/FCF Ratio	53.66	30.40	-	-	-	44.06
P/OCF Ratio	46.89	26.56	-	-	-	37.99
EV/Sales Ratio	9.88	5.52	686.02	11.63	13.09	43.51
EV/EBITDA Ratio	59.07	37.47	-	-	-	-
EV/EBIT Ratio	83.36	46.58	-	-	-	-
EV/FCF Ratio	52.72	29.20	-	-	-	40.72
Debt / Equity Ratio	1.46	1.46	4.46	1.34	0.20	0.06
Debt / EBITDA Ratio	5.29	5.29	-	-	-	-
Debt / FCF Ratio	4.68	4.68	-	-	-	0.17
Asset Turnover	0.66	0.66	0.00	0.33	0.35	0.22
Quick Ratio	4.73	4.73	6.57	3.75	2.67	2.58
Current Ratio	4.86	4.86	6.74	3.95	2.92	2.63
Return on Equity (ROE)	8.67%	8.67%	-254.98%	-59.33%	-42.68%	-32.36%
Return on Assets (ROA)	4.87%	4.87%	-39.43%	-17.58%	-15.91%	-15.11%
Return on Capital (ROIC)	5.39%	5.39%	-43.84%	-21.89%	-23.88%	-20.31%
Return on Capital Employed (ROCE)	8.30%	8.30%	-58.00%	-31.10%	-32.30%	-26.40%
Earnings Yield	-0.02%	-0.03%	-24.90%	-7.13%	-5.03%	-2.16%
FCF Yield	1.86%	3.29%	-25.10%	-11.48%	-5.40%	2.27%
Buyback Yield / Dilution	-11.67%	-11.67%	-12.21%	-1.26%	-1.62%	-3.00%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.